In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concentrations of NaF (5%), some in vitro data have suggested that they may differ in the amount of fluoride release. Determining fluoride release of these varnishes in vivo is important in assessing both the safety and efficacy of the product.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Desensitizing Effect and Tooth Color Change After Using Giomer-based Varnish Versus Bioactive Glass Air Polishing in Treating Cervical Hypersensitive Lesions

NCT05981625

Dentin Hypersensitivity, Non-carious Cervical Lesions, Bioactive Glass Air Polishing, S-PRG

NOT_YET_RECRUITING NA

Long-term Release of Fluoride Formed on Enamel by Fluoride Gel or Varnish to Biofilm Fluid

NCT02486458

Dental Caries

COMPLETED EARLY_PHASE1

In Vivo Evaluation of an Experimental Fluoride-containing Dentifrice With Hydrocolloid

NCT02809014

Dental Caries

COMPLETED NA

Remineralization Efficacy of Gum Arabic Varnish.

NCT04422860

Caries,Dental Remineralization White Spot Lesion

UNKNOWN PHASE2/PHASE3

Effectiveness Silver Diamine Fluoride Versus Sodium Fluoride in Arresting Caries Around Crown Margins in Older Adults

NCT04255251

Caries Roots Flouride Varnish Caries; Dentin +1 more

UNKNOWN EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be a cross-over single blinded clinical study to evaluate the in vitro fluoride release of three different brands of 5% NaF varnish. Subjects will be recruited at the University of Michigan School of Dentistry and will participate in a 15 minute clinical session at the beginning of each study arm, followed by 6 saliva collection recalls. During these sessions a fluoride varnish or placebo will be applied to their teeth, and subsequent salivary samples will be taken 1 hour, 4 hours, 6 hours, 24 hours, and 48 hours after the application. All subjects will receive 3 commercially available varnishes, and a placebo varnish. Between applications there will be a minimum of 2 weeks wash-out period. The goal of this study is to determine if different formulations of varnish lead to differing amounts of fluoride release. Despite their similar concentrations of NaF (5%), some in vitro data have suggested that they may differ in the amount of fluoride release. Determining fluoride release of these varnishes in vivo is important in assessing both the safety and efficacy of the product.

Specific Aims

1. Determine the concentration of fluoride available in the oral cavity at different time periods after the application of three different 5% NaF varnishes as measured in unstimulated human saliva.
2. Compare the different patterns of fluoride release from each of the varnishes by comparing the fluoride concentration in saliva at corresponding time periods .
3. Evaluate the validity of an in vitro model used to measure fluoride release from varnishes.

Percentage difference in fluoride release between the in vivo and in vitro data obtained from the same products will be compared. Because the comparison of different patterns of fluoride release from the varnishes is accomplished by analyzing the fluoride available concentration levels, it was an error to list that secondary aim as a secondary - or indeed any sort of outcome measure. The outcome measure data for "patterns of fluoride release" is exactly that which has been fully disclosed in the Primary Outcome Measure data tables. Therefore the secondary outcome measure previously listed: Compare the different patterns of fluoride release from each of the varnishes, which was really never properly an outcome measure, but an aim, has been deleted, with no loss of data transparency.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enamel Pro

Varnish containing 5%NaF

Group Type ACTIVE_COMPARATOR

Enamel Pro

Intervention Type DEVICE

Varnish treatment containing 5% NaF

Duraphat

Varnish containing 5%NaF

Group Type ACTIVE_COMPARATOR

Duraphat

Intervention Type DEVICE

Varnish treatment containing 5% NaF

Vanish

Varnish containing 5%NaF

Group Type ACTIVE_COMPARATOR

Vanish

Intervention Type DEVICE

Varnish treatment containing 5% NaF

Placebo

Bland varnish containing no NaF

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DEVICE

Bland varnish containing no NaF

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enamel Pro

Varnish treatment containing 5% NaF

Intervention Type DEVICE

Duraphat

Varnish treatment containing 5% NaF

Intervention Type DEVICE

Vanish

Varnish treatment containing 5% NaF

Intervention Type DEVICE

Placebo

Bland varnish containing no NaF

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Varnish Varnish Varnish Bland varnish

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* Subjects with less than 20 teeth
* Subjects with significant untreated disease to include gum disease, extensive decay, or the need for pre-medication prior to dental treatment
* Pregnant or lactating women
* Subjects with a history of allergy to materials to be used in the study
* Subjects unable to produce adequate saliva for sampling
* Subjects deemed low risk for dental caries (no history of restorative work or presence of caries lesions)
* Subjects unable to be available for all 4 cycles of the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes